MX2022000803A - Formulaciones de capsula de cubierta blanda y metodos de preparacion y uso de las mismas. - Google Patents

Formulaciones de capsula de cubierta blanda y metodos de preparacion y uso de las mismas.

Info

Publication number
MX2022000803A
MX2022000803A MX2022000803A MX2022000803A MX2022000803A MX 2022000803 A MX2022000803 A MX 2022000803A MX 2022000803 A MX2022000803 A MX 2022000803A MX 2022000803 A MX2022000803 A MX 2022000803A MX 2022000803 A MX2022000803 A MX 2022000803A
Authority
MX
Mexico
Prior art keywords
methods
softshell
preparation
capsule formulations
softgel
Prior art date
Application number
MX2022000803A
Other languages
English (en)
Inventor
Linus Gomsi Fonkwe
Jean Magloire Kameni
Ronak Savla
Neftali Tosado
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of MX2022000803A publication Critical patent/MX2022000803A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describen en la presente formas de dosificación de gel blando, por ejemplo, cápsulas de gel blando de aspirina estables. También se describen en la presente métodos para preparar tales formas de dosificación de gel blando y métodos de uso de las mismas.
MX2022000803A 2019-07-23 2020-07-22 Formulaciones de capsula de cubierta blanda y metodos de preparacion y uso de las mismas. MX2022000803A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962877580P 2019-07-23 2019-07-23
PCT/US2020/042992 WO2021016305A1 (en) 2019-07-23 2020-07-22 Softshell capsule formulations, and methods of preparation and use thereof

Publications (1)

Publication Number Publication Date
MX2022000803A true MX2022000803A (es) 2022-05-18

Family

ID=74194254

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022000803A MX2022000803A (es) 2019-07-23 2020-07-22 Formulaciones de capsula de cubierta blanda y metodos de preparacion y uso de las mismas.

Country Status (7)

Country Link
US (1) US20220280436A1 (es)
EP (1) EP4003310A4 (es)
BR (1) BR112022001165A2 (es)
CA (1) CA3148082A1 (es)
CO (1) CO2022001783A2 (es)
MX (1) MX2022000803A (es)
WO (1) WO2021016305A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112826807B (zh) * 2021-01-29 2022-10-04 北京航洋健康科技有限公司 一种软胶囊囊壳及由其制备的软胶囊及其制备方法
AU2022362830A1 (en) * 2021-10-11 2024-02-29 Plantic Technologies Ltd Resin composition and method for producing same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650232A (en) * 1994-10-07 1997-07-22 Warner-Lambert Company Method for making seamless capsules
US6340473B1 (en) * 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
GB0314832D0 (en) * 2003-06-25 2003-07-30 Phoqus Pharmaceuticals Ltd Production of capsule shells and capsules
US8231896B2 (en) * 2004-11-08 2012-07-31 R.P. Scherer Technologies, Llc Non-gelatin soft capsule system
US20090030057A1 (en) * 2005-11-22 2009-01-29 Shlomit Wizel Pharmaceutical composition of telmisartan
US20090214641A1 (en) * 2008-02-26 2009-08-27 Joar Opheim Sweetened Capsules for Administration
US8518438B2 (en) * 2011-01-14 2013-08-27 Enspire Group, Llc Highly concentrated liquid acetaminophen solutions
WO2014152098A1 (en) * 2013-03-15 2014-09-25 Banner Pharmacaps Inc. Non-gelatin enteric soft capsules
JP2016160227A (ja) * 2015-03-03 2016-09-05 中日本カプセル 株式会社 ソフトカプセル皮膜の製造方法及びソフトカプセル皮膜
US20180049999A1 (en) * 2015-04-14 2018-02-22 Atossa Genetics Inc. Compositions and methods of treatment of breast disorders and estrogen-related disorders

Also Published As

Publication number Publication date
EP4003310A4 (en) 2023-08-02
EP4003310A1 (en) 2022-06-01
CA3148082A1 (en) 2021-01-28
BR112022001165A2 (pt) 2022-05-17
US20220280436A1 (en) 2022-09-08
CO2022001783A2 (es) 2022-04-08
WO2021016305A1 (en) 2021-01-28

Similar Documents

Publication Publication Date Title
MX2023007033A (es) Extractos de cannabis y metodos de preparacion y uso de la misma.
EA201792592A1 (ru) Фармацевтические препараты, содержащие тенофовир и эмтрицитабин
MA40539A (fr) Procédés de formulation de compositions de conjugués anticorps-médicaments
MX2019011491A (es) Formulaciones de niraparib.
PH12020550815A1 (en) Delayed release deferiprone tablets and methods of using the same
MX2018012618A (es) Composiciones farmaceuticas orales de mesalazina.
MX2022000803A (es) Formulaciones de capsula de cubierta blanda y metodos de preparacion y uso de las mismas.
PH12015502721B1 (en) Pharmaceutical capsule composite formulation comprising tadalafil and tamsulosin
CU20210077A7 (es) Extractos bacterianos estables como fármacos
PH12019500154A1 (en) Formulation having improved ph-dependent drug-release characteristics, containing esomeprazole or pharmaceutically acceptable salt thereof
MX2017013636A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde diferentes particulas.
JOP20220160A1 (ar) مركبات فعّالة نحو مستقبلات نووية
IL291953A (en) Formulations of non-animal soft gel capsules, methods of preparation and methods of use thereof
MX2022007265A (es) Compuestos activos frente a receptores nucleares.
MX2017005163A (es) Composiciones de liberación prolongada de onapristona y métodos.
EA202090913A1 (ru) Композиция таблеток с модифицированным высвобождением, содержащая мирабегрон
MX2017013633A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas.
MX2018010065A (es) Forma de dosificacion oral que comprende rifaximina en forma beta.
EA201991286A1 (ru) Твердая фармацевтическая композиция для перорального применения, содержащая тенофовир и эмтрицитабин
PH12020551547A1 (en) Pharmaceutical preparation
MX2017000384A (es) Forma de dosificacion en capsulas de succinato de metoprolol.
MX2020012233A (es) Formula de suspension de alta concentracion para medicamentos en capsula de gel blanda para resfriado y gripe.
MX2017013643A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y una matriz.
MX2021004438A (es) Preparaciones de extracto botanico pulverizado y formulaciones de las mismas.
MX2019015869A (es) Nuevas formulaciones orales de belinostat.